Becigard 7.5mg Tablet
Prescription Required
Product introduction
Becigard 7.5mg Tablet is a muscarinic antagonist that is used in the treatment of overactive bladder. It relieves urinary symptoms like frequent urination, urgent need to urinate, and inability to control urination.
Becigard 7.5mg Tablet is used to treat symptoms of overactive bladder that include sudden urge to pass urine, uncontrollable desire to pass urine, etc.
Becigard 7.5mg Tablet is used to treat symptoms of overactive bladder that include sudden urge to pass urine, uncontrollable desire to pass urine, etc.
Uses of Becigard Tablet
Benefits of Becigard Tablet
In Treatment of Overactive bladder (OAB) symptoms
Becigard 7.5mg Tablet helps to treat uncontrollable contractions (spasms) of the bladder muscles that causes frequent urination, urgent need to urinate, and inability to control passing of urine. It also relieves painful, or frequent urination and reduces urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.
Side effects of Becigard Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Becigard
- Constipation
- Dryness in mouth
- Headache
- Dry eye
- Nasal dryness
How to use Becigard Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Becigard 7.5mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Becigard 7.5mg Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Becigard 7.5mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Becigard 7.5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Becigard 7.5mg Tablet may cause side effects which could affect your ability to drive.
Becigard 7.5mg Tablet may cause effects such as dizziness, blurred vision, trouble sleeping or drowsiness. This may affect your driving ability.
Becigard 7.5mg Tablet may cause effects such as dizziness, blurred vision, trouble sleeping or drowsiness. This may affect your driving ability.
Kidney
SAFE IF PRESCRIBED
Becigard 7.5mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Becigard 7.5mg Tablet is recommended.
However, inform your doctor if you have any underlying kidney disease.
However, inform your doctor if you have any underlying kidney disease.
Liver
CAUTION
Becigard 7.5mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Becigard 7.5mg Tablet may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Becigard 7.5mg Tablet
₹29.81/Tablet
Urifen 7.5mg Tablet
Ajanta Pharma Ltd
₹23.5/tablet
21% cheaper
Deyten OD 7.5mg Tablet
Globus Labs
₹22.5/tablet
25% cheaper
Xelena 7.5mg Tablet
Dr Reddy's Laboratories Ltd
₹21.15/tablet
29% cheaper
StayHappi Darifenacin 7.5mg Tablet
Sarvagunaushdhi Pvt Ltd
₹12/tablet
60% cheaper
Darinacin 7.5mg Tablet
ANT Pharmaceuticals Pvt Ltd
₹22.8/tablet
24% cheaper
Quick tips
- Becigard 7.5mg Tablet helps you to have better control over your urination by relaxing your bladder which increases its capacity to hold urine, thereby reducing the need to pass urine.
- It may cause blurred vision, fatigue and sleepiness. Be cautious while driving or doing anything that requires focus.
- It may cause dry mouth. Try chewing on sugar-free gum or taking small sips of water.
- Avoid caffeine, alcohol or carbonated drinks as they can worsen your symptoms.
- Do not stop taking this medicine if you do not notice an improvement in your symptoms as it may take some time for your bladder to adapt and your symptoms to improve.
Fact Box
Chemical Class
Diphenylmethane Derivative
Habit Forming
No
Therapeutic Class
UROLOGY
Action Class
Selective M3 anticholinergic (Bladder)
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 359.
- Darifenacin. Luxembou: Merus Labs Luxco II S.à R.L; 2004 [revised 12 Jan. 2015]. [Accessed 04 Apr. 2019] (online) Available from:
- Drugs.com.Darifenacin. [Accessed 04 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:
Marketer details
Name: Cipla Ltd
Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Country of origin: India
Lab tests offered by us
Related/Popular tests
29 people viewed this recentlyMRP
₹298.14
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me